Our products are available in 62 countriesClick here to learn more
Egis activities extend to every field of the pharmaceutical value chainClick here to learn more
Egis is an innovation-oriented generic pharma company, one of the regional industry leaders.Click here to learn more
The 11th Russian Pharma Awards ceremony was held on November 24th in Moscow. Based on the results of voting by Russian medical practitioners, Egis' iron-containing product was recognized as the absolute leader in the category "Treatment of anemia in pregnant and lactating women". More than 430 thousand doctors were invited to vote at the communication platform "Doctor at Work".
The project "Improving the living conditions of children in orphanages in Yaroslavl" was recognized as the best in the nomination "Projects to Support Socially Vulnerable Groups of People".
Two technology-intensive developments, carried out with state subsidies, were completed at Egis Pharmaceuticals PLC’s Körmend site (Hungary). The investments were inaugurated by Péter Szijjártó, Minister of Foreign Affairs and Trade, and by the company’s CEO, Dr. István Hodász on 15 October. In addition to a new packaging plant, Egis has also established a plant with special knowledge and technology requirements, typically suitable to manufacture oncology products. Thus, Egis is now able to implement all value-creating processes within the field of oncology, from development to active ingredient and finished product manufacturing.
Please report any adverse events